| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26f66a8943279c4a02eda00b1edfcc71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-202 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8b0649e2845a10e5432a2327dd8bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a160a86ffab3cc1321beb71255eb0b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e87f32b5e25c9543b49c52892ec3b1fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_778ca251c1307d0008025d75e90ee117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c09bf92b413a6df5505c76c67c60364 |
| publicationDate |
2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020190023-A9 |
| titleOfInvention |
Method for treating atopic dermatitis using monoclonal stem cells |
| abstract |
The present invention pertains to a method and a composition for preventing or treating atopic dermatitis through the administration of monoclonal stem cells. The present invention also pertains to a composition and a method for selecting atopic dermatitis patients suitable for the administration of monoclonal stem cells and predicting the prognosis of the patients in order to apply the prevention or treatment method and composition. According to an improved method for the layer separation culturing and proliferation of stem cells of the present invention, large quantities of desired monoclonal mesenchymal stem cells can be obtained in a short period of time through the rapid proliferation of monoclonal mesenchymal stem cells. In addition, the monoclonal mesenchymal stem cells thus obtained can be administered to atopic dermatitis patients according to a prescribed administration cycle, guidelines, and dose to effectively ameliorate atopy symptoms in the patients. Moreover, by using a marker to identify patient groups particularly suitable for the treatment and selectively administering the monoclonal mesenchymal stem cells to the patient groups, an excellent therapeutic effect for atopic dermatitis can be achieved. |
| priorityDate |
2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |